Form 8-K - Current report:
SEC Accession No. 0000950170-22-019872
Filing Date
2022-10-24
Accepted
2022-10-24 07:00:36
Documents
12
Period of Report
2022-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K stro-20221018.htm   iXBRL 8-K 49923
  Complete submission text file 0000950170-22-019872.txt   166922

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20221018.xsd EX-101.SCH 2464
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20221018_lab.xml EX-101.LAB 13466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20221018_pre.xml EX-101.PRE 10989
6 EXTRACTED XBRL INSTANCE DOCUMENT stro-20221018_htm.xml XML 4752
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 221324812
SIC: 2836 Biological Products, (No Diagnostic Substances)